100
Participants
Start Date
September 6, 2021
Primary Completion Date
December 31, 2025
Study Completion Date
June 30, 2026
Ketamine
Racemic ketamine® will be administered by continuous infusion in a prefilled 50 ml syringe at a concentration of 50 mg/ml, undiluted. The ketamine dose is 1 mg/kg/h, to a maximum dose of 120 mg/hour, which corresponds to an infusion rate of 0.02 ml/kg/h to a maximum rate of 2.4 ml/h.
Placebo
Placebo (NaCl 0.9%) will be provided in the same type syringes and administered at the same infusion rate as the IMP (0.02 ml/kg/h to a maximum rate of 2.4 ml/h).
RECRUITING
UZLeuven, Leuven
RECRUITING
Jessa Ziekenhuis, Hasselt
RECRUITING
Imelda Bonheiden, Bonheiden
RECRUITING
AZ Sint-Jan, Bruges
RECRUITING
CHR de la Citadelle Liège, Liège
RECRUITING
CHU de Liège, Liège
RECRUITING
AZ Delta, Roeselare
RECRUITING
AZ Turnhout, Turnhout
Collaborators (1)
University of Liege
OTHER
Centre Hospitalier Régional de la Citadelle
OTHER
AZ Delta
OTHER
AZ Sint-Jan AV
OTHER
AZ Turnhout
OTHER
Imelda Hospital, Bonheiden
OTHER
Geert Meyfroidt, MD, PhD
OTHER